Connect with us

Latest News

Recruiting Industry Experts is Key to Success for Cannabis Companies

Published

on

Reading Time: 6 minutes

 

The cannabis industry is seen by professionals as one of the most exciting fields to participate in, with many companies attracting some of the brightest industry experts to join them. Agraflora Organics International (CSE:AGRA) (OTC:PUFXF), National Access Cannabis Corp (CSE:META) (OTC:NACNF), CBD Unlimited, Inc (CSE:EDXC) (OTC:EDXC), FSD Pharma Inc (CSE:HUGE) (OTC:FSDDF) and Chemistree Technology Inc(OTC:CHMJF) (CSE:CHM) have all been working hard to sign on cannabis experts in an effort to gain a competitive advantage over their competition.

As the relatively young cannabis industry continues to mature, one of the best predictors of whether a company will survive in the years to come is the strength of its management team. With becoming increasingly fierce, companies led by management teams with plenty of experience – drawn from both within and outside the cannabis industry – have historically had the best likelihood of success. While every company strives to enlist top cannabis industry veterans – the truth of the matter is, these individuals are a rare find. The addition of experts to any cannabis company not only is a big deal in terms of publicity, but also a strong indicator of future success.

The Importance of Experienced Management Teams

The sheer growth potential of the cannabis industry has attracted some of the best executive talents across the world. According to Grand View Research, marijuana is predicted to become a $146.4 billion market globally by 2025, representing a 34.6 percent increase every year. With such growth opportunities available, it’s not surprising why many executives from Fortune 500 companies chose to leave their safe and conventional career paths to take a risk in the cannabis sector.

Recent Expert Partnerships

Cannabis companies are bringing in experts from diverse backgrounds. Depending on the type of cannabis company, the list of experts includes professionals ranging from cannabis market veterans to retail and healthcare professionals, and even law enforcement. The board of Agraflora Organics International Inc (CSE:AGRA) (OTCMKTS:PUFXF) boasts twolongtime Toronto Police officers on their management team. While, FSD Pharma Inc (CSE:HUGE) (OTCMKTS:FSDDF) is headed by physician turned entrepreneur, Dr. Dr Raza Bokhari, Executive Co-Chairman & Interim CEO.

As such, it’s not surprising that cannabis companies go out of their way to partner with high profile figures. Last month, Aurora Cannabis Inc announced it was partnering with billionaire Nelson Peltz. The relationship would help the cannabis giant better position itself for potential retail partnerships.

A much smaller company, Chemistree Technology Inc (OTCQB:CHMJF) (CSE:CHM), recently made news as well when it signed on legendary cannabis industry veteran Nicholas J. Zitelli – known within the industry by his pen name “Nico Escondido”. As one of the most knowledgeable experts in the cannabis space, Nico Escondido has written hundreds of articles about the cannabis industry and best practices. He also founded the Cannabis Genetics Institute (CGI) in AmsterdamHolland, helping create custom cannabis strains to treat various medical conditions. Besides all of this, Nico Escondido is best known for being a principal at the High Times brand.

With a monthly magazine in publication since 1974, High Times is one of the best-known groups promoting and developing the cannabis culture. Publishing numerous books and documentaries, High Times also hosts the most prestigious marijuana-related competition in the world. The “Cannabis Cup” brings together industry experts, cannabis enthusiasts, and marijuana companies together across the world and holds contests in various product categories.

“I am very excited to join the Chemistree team” said Nico Zitelli in a press release. “Having known and worked with many of the team members in the past, I am confident we will be able build significant value in the Company and help define the future of the cannabis industry.”

For a company like Chemistree Technology Inc (CHMJF) (CHM), getting Zitelli on board is a big deal. As an early investor in the international cannabis sector that’s expanding their vertically integrated operations, the addition of Nico Zitelli to Chemistree Technology Inc (CHMJF) (CHM) will give the company the industry clout it needs to stand out in the market.

“As Chemistree continues its focus on building one of the world’s leading cannabis companies, it is critical to have an experienced board to put us in the best possible position to achieve success.  These are exciting times for Chemistree and Nico represents another outstanding addition to our board of directors on our path of rapid growth,” added Chemistree Technology Inc (CHMJF) (CHM) President Karl Kottmeier. “The High Times Cannabis Cup is the most prestigious and extensive cannabis-related competition in the world and having his broad knowledge/specialized expertise, impressive network and reputation will be invaluable assets to the Company’s strategic direction.”

It’s common for massive, multi-billion-dollar cannabis companies to boast impressive hires within the industry. Chemistree Technology Inc (CHMJF) (CHM), on the other hand, is a company with less than $20 million in market capitalization. The fact that this small cannabis company has signed on one of the top industry experts in cannabis is a major accomplishment for the firm. In comparison, few other companies of a similar size can expect such a major name to come on board – something that will propel Chemistree Technology Inc (OTCQB:CHMJF) (CSE:CHM) to a class well above its peers.

Further Cannabis Developments

Back in late March, Agraflora Organics International Inc (CSE:AGRA) (OTCPK:PUFXF) announced they had fully invested a $40 million equity participation agreement with Delta Organic Cannabis Corp. The agreement would see Agra own a 50 percent stake in the second largest cannabis greenhouse in Canada.

In a recent press release, National Access Cannabis Corp (CSE:META) (OTCPK:NACNF)  announced their financial figures for their operations since federal legalization. The company achieved over $20 million in retail sales since October 17, 2018. National Access Cannabis has 23 stores across Alberta and Manitoba and is the largest private cannabis retailer in the country. The company is headed by a team with years of experience in retail and healthcare.

Todd A. Davis, Co-Founder and CEO of CBD Unlimited, Inc (CSE:EDXC) (OTCPK:EDXC), formerly known as Endexx Corporation,  brings to the team years of experience in investment banking and entrepreneurship. The company has recently employed a private sales group to help expand the company’s product reach both in Canada as well as internationally. Initially launching as a 25-person sales team, CBD Unlimited is expected to grow this salesforce to up to 500 in the next two years.

Another cannabis company that made a major management team announcement was FSD Pharma Inc (CSE:HUGE) (OTCQB:FSDDF). In a recent press release, the company announced that Dr. Charles Pollack would be joining FSD as the Chairman of their Scientific Board. He brings a long history of clinical research in the areas of pain treatment, thrombosis, and reversing anticoagulation.

For a free research report on Chemistree (CSE:CHM) (OTC:CHMJF), visit potstocknews.com

Disclaimer: Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated forty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of Chemistree Technology Inc.

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and PSN and FNM undertake no obligation to update such statements.

 

SOURCE Potstocknews.com

Artificial Intelligence

Experienced Industry Veteran Tony Mingo Joins O’Neil Digital Solutions

Published

on

Tony Mingo, Managing Director, Professional Services

 

O’Neil Digital Solutions (ODS), a leader in data-driven publishing and plan sponsor/participant communication services, recently announced that long-time financial technology (fintech) veteran Tony Mingo has joined the organization as its Managing Director, Professional Services in the financial vertical.

Mingo’s role is “to assist cutting-edge companies in their data-transformation strategies.”

Before joining ODS, Mingo founded vWise, Inc., a retirement plan participant digital thought-leader, in 2006, with a vision of creating interactive solutions that engage employees with their benefits. His experience as a leader in the financial services industry spans over 28 years, with additional experience in executive management leadership within the technology industry in Silicon Valley.

“With Tony’s experience and relationships in the financial industry, we are excited to have him build and lead our Professional Service in the Financial division at ODS,” said Terry Chan, President and COO of ODS.

Mingo will focus on growing the software and professional services offerings for the firm’s financial and insurance lines of business.

“It’s about delivering a proven digital transformation strategy, from traditional output to Omni-channel conversion, as well as process improvement, change management, and SAAS platforms that serve six different verticals (retirement, banking, brokerage, property/casualty, wealth management and life insurance/annuity),” Mingo said. “It has never been more imperative that organizations provide world-class customer experiences to plan participants to strengthen their reputations and brand loyalty. Meeting these expectations requires a deeper understanding of an individual customer’s needs across the entire customer journey.”

In early 2019, O’Neil launched its Plan Health Dashboard. The Plan Health Dashboard uses a client’s plan analytics to assign a plan health score based on underlying metrics such as participation rates, income replacement ratios, and asset diversification. The metrics can be weighted to define the scoring methodology.

ODS’ Omni-channel solution, called ONEsuite, provides clients with a flexible platform to create, manage and deliver highly-personalized marketing, sales and business documents in any media and format requested by an audience.

 

SOURCE O’Neil Digital Solutions

Continue Reading

Artificial Intelligence

Konnect -Volkswagen Group Innovation Hub TLV, Chose Seebo as the Winner of Its Startups Challenge

Published

on

 

Seebo, a pioneer in process-based Artificial Intelligence, announced today it has won the Konnect- VW Group Innovation hub TLV Startups Challenge. Seebo was chosen following a tough judging process, by a jury of experts from the Volkswagen Group leading car brands such as Volkswagen, Audi, SEAT, Skoda, Porsche, VW Commercial Vehicles and more.

The goal of the challenge was to find technologies that present clear business potential, cost reduction, and address real challenges.” Says Stephanie Vox, Managing Director, Konnect. “Seebo’s solution is market-ready and can rapidly impact production efficiency and costs. It was chosen based on the Volkswagen Group high standards and commitment to deliver to our customers top quality cars today and in the future.”

Seebo was selected out of dozens of start-ups that participated in the challenge. The prize recognizes Seebo’s ground-breaking technology and ensures a deep collaboration with the VW Group, for which a sum of up to 25K Euros is granted.

We are honored to have been chosen as winners of the Smart Startups Challenge for 2019, by the leading VW Group brands, which are known for quality and innovation.” Says Lior Akavia, Seebo co-founder and CEO. “We look forward to this collaboration and to being part of the VW Group on-going pursuit for improvement in production efficiency and excellence.

Seebo enables automotive manufacturers to reduce processes-driven quality losses and failures in production and assembly processes. Collecting and analyzing data from production lines and automated inspection systems, Seebo leverages predictive analytics and automated root-cause analysis, to ensure production efficiency is kept at its highest level.

 

SOURCE Seebo

Continue Reading

Artificial Intelligence

Innovative Healthcare Startup Kermit Leverages Mendix-built Analytics Platform to Expand Services Nationwide

Published

on

 

Mendix, a Siemens business and the global leader in low-code and no-code application development for the enterprise, today announced that Kermit, the first spend-management platform for hospitals in the area of implantable medical devices, is announcing plans to expand their services nationwide. Kermit’s innovative analytics platform, enabling hospitals to track and manage contracts, billings, and vendor compliance, was built with a single Mendix developer in less than a year. Today’s announcement underscores the fact that low code technology from Mendix is ripe for implementation within the healthcare industry.

As knee, hip, and cardio implants move from package to patient, the Mendix-built platform captures data and provides end-to-end visibility into a supplier category known for its notoriously opaque pricing and batch invoicing. With Kermit, the accurate cost and use of each medical device is captured on handheld devices as the medical item moves from point-of-service in the operating room, accurate patient billing and vendor invoice payment, and finally aggregated for contract negotiations by healthcare executives. The data-driven analytics platform transforms a hospital’s previously siloed, paper- and spreadsheet-based data collection system into a cost-savings tool that flags supplier trends, optimizes workflows and spending, and provides quick dashboard reporting that has been proven to save hospitals millions of dollars.

“We are thrilled to announce our plans to expand the Kermit services nationwide,” says Richard Palarea, CEO and co-founder of Kermit, whose company now manages 40% of the total implant spend transacting in Maryland. “Our goal is not only to provide better data and save money for resource-strapped hospitals. We also want to shine a light on fraud and abuse within the medical device marketing industry and align value and spend management initiatives for the people that dedicate their lives to saving others. Our customers are now seeing significant savings in their medical device spending category. We wouldn’t have been able to achieve all this had it not been for Mendix. We built our platform using Mendix, and I attribute a large portion of our success to the ease of using Mendix’s low-code platform.”

Providing transparency and control

Fraud and abuse often run rampant in the sales and marketing of drugs and medical devices and is difficult to track across the healthcare industry’s siloed or proprietary data warehouse systems. Kermit provides a transparent analytics platform for surgeons, supply chain managers, and healthcare executives that connects medical device data to robust visualization and analysis, empowering the full team to make quality decisions on behalf of the patient. For surgeons, the platform provides an easy and transparent way to review the costs of implantable medical devices while discussing options with patients. Kermit also ensures fair and accurate billing by keeping cases, contracts, and devices updated and organized for supply chain managers. Additionally, Kermit pulls in external business intelligence such as supplier spending trends, contract compliance, and FDA recalls of medical devices. Such items, flagged for healthcare executives and procurement managers, provide knowledge and insight on device-related inefficiencies, equipping hospital to better navigate the ever-changing reimbursement environment.

Saving hospitals millions

Hospitals are working under immense pressure to manage costs and increase savings, with many operating on profit margins of 3 percent or less. Kermit’s founding principle is to return the balance of power back to the hospital by exposing ways to eliminate millions of dollars per year in the category of medical device spending and improving patient care. The University of Maryland Medical System, which has used the Kermit analytics platform over the course of two years, has achieved upwards of $30 million in savings, with greater visibility to vendor activity and collaboration between supply chain and surgeons. Hospitals in the mid-Atlantic region that have adopted Kermit report saving 30% on average of their total implant spend per year.

Built in nine months

Palarea cites Mendix’s flexible approach to rapid application development as a key competitive differentiator. “Without Mendix, it would have taken us nearly twice as long to develop our product and required us to hire five to ten developers instead of one,” he says. “We would have lost the window of being first to market this innovative approach.”

Mendix’s cloud-native capability enables Kermit to bypass hospital firewalls for additional time and efficiency gains. “Hospital IT departments can be bottlenecks,” Palarea admits. “Enterprise solutions can take between one to three years to implement. However, our customers access our Mendix-built platform via web browsers and connectivity. This lets Kermit bypass IT involvement and deploy our solution in less than seven days.”

The healthcare industry’s digital transformation depends on healthy data. “To leverage the inherent promise of big data analytics in the healthcare supply chain of medical devices is only achieved with a deep understanding of what customers and end users truly need and use on a daily basis,” says Jon Scolamiero, Mendix manager, architecture and governance. “Mendix’s application development tools are designed to foster collaboration between business experts and professional developers. Working together, they can build and deploy responsive, mission-critical applications that quickly make an impact.”

Palarea agrees. “Mendix has allowed us to be extremely nimble and flexible,” he says. “We are literally innovating in the midst of our hospital customers who are unaccustomed to seeing value delivered so rapidly and well below the expected budget numbers.”

Continue Reading

Trending

Roboticulized is a news publishing website which digests / hand picks the latest news about the AI industry, and serves them to you daily.

Contact us: pressroom@roboticulized.com

© Roboticulized.com 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania